Harvard bioscience, inc. to participate in march 2024 investor conferences: sidoti's small cap conference and keybanc's life sciences & medtech conference

Holliston, mass., march 11, 2024 (globe newswire) -- harvard bioscience, inc. (nasdaq: hbio) today announced that jim green, chairman and chief executive officer, will be presenting to investors at the upcoming sidoti small cap conference and keybanc life sciences & medtech conference, both to be held virtually in march 2024. joining him will be jennifer cote, the company's chief financial officer.
HBIO Ratings Summary
HBIO Quant Ranking